Prophylaxis antiretroviral drugs hiv seropositivity. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy3

CD4-Positive T-Lymphocytes Plasma Genitalia, Female

Organisms12

HIV-1 HIV Chlamydophila pneumoniae Helicobacter pylori Cytomegalovirus Herpesvirus 2, Human HIV-2 Toxocara Simian immunodeficiency virus Toxoplasma Neospora Hepatitis A Virus, Human

Diseases32

HIV Seropositivity HIV Infections Substance Abuse, Intravenous Acquired Immunodeficiency Syndrome Pregnancy Complications, Infectious AIDS-Related Opportunistic Infections HIV-Associated Lipodystrophy Syndrome Viremia HIV Wasting Syndrome Chlamydophila Infections Cytomegalovirus Infections Lipodystrophy Coinfection Hepatitis C Helicobacter Infections AIDS Dementia Complex Tuberculosis Toxocariasis Toxoplasmosis Immune Reconstitution Inflammatory Syndrome Pneumonia, Pneumocystis Disease Progression Hepatitis B Simian Acquired Immunodeficiency Syndrome Papillomavirus Infections Herpes Genitalis Surgical Wound Infection Syphilis Hepatitis A Venous Thromboembolism Lymphoma, AIDS-Related Sarcoma, Kaposi

Chemicals and Drugs52

Anti-HIV Agents Anti-Retroviral Agents Reverse Transcriptase Inhibitors HIV Protease Inhibitors Zidovudine Benzoxazines Nevirapine Organophosphonates HIV Reverse Transcriptase Indinavir Lopinavir Ritonavir Stavudine Lamivudine HIV Protease HIV Fusion Inhibitors RNA, Viral Nelfinavir Adenine Pyrimidinones Integrase Inhibitors Didanosine Saquinavir Antibodies, Viral HIV Integrase Inhibitors Antiviral Agents Antibodies, Bacterial Dideoxynucleosides pol Gene Products, Human Immunodeficiency Virus Immunoglobulin G Oxazines Cyclohexanes Trimethoprim-Sulfamethoxazole Combination Drugs, Generic Pyrrolidinones Zalcitabine HIV Envelope Protein gp41 Protease Inhibitors DNA, Viral Drugs, Investigational Drug Combinations Antitubercular Agents Receptors, CCR5 Antibodies, Protozoan HIV Antibodies Gene Products, pol Pyridines HIV Envelope Protein gp120 Triazoles Oligopeptides HIV Antigens Immunoglobulin A

Analytical, Diagnostic and Therapeutic Techniques and Equipment38

HIV Seroprevalence Antiretroviral Therapy, Highly Active Risk Factors CD4 Lymphocyte Count Antibiotic Prophylaxis Viral Load Seroepidemiologic Studies Drug Therapy, Combination Cohort Studies Prevalence Treatment Failure Treatment Outcome Prospective Studies Cross-Sectional Studies Retrospective Studies Drug Monitoring Dental Prophylaxis Drug Administration Schedule Chemoprevention Incidence Serologic Tests Enzyme-Linked Immunosorbent Assay Follow-Up Studies Longitudinal Studies Logistic Models AIDS Serodiagnosis Premedication Case-Control Studies Clinical Trials as Topic Lost to Follow-Up Multivariate Analysis Sequence Analysis, DNA Odds Ratio Microbial Sensitivity Tests Polymerase Chain Reaction Directly Observed Therapy Sensitivity and Specificity Questionnaires

Psychiatry and Psychology9

Substance Abuse, Intravenous Sexual Behavior Medication Adherence Patient Compliance AIDS Dementia Complex Homosexuality, Male Risk-Taking Breast Feeding Homosexuality

Phenomena and Processes19

Drug Resistance, Viral CD4 Lymphocyte Count Viral Load Drug Resistance, Multiple, Viral HIV Seronegativity Pregnancy Virus Replication Genotype Time Factors Mutation Drug Interactions Genes, pol Homosexuality, Male Odds Ratio Mutation, Missense Breast Feeding Homosexuality Drug Resistance, Microbial Sensitivity and Specificity

Anthropology, Education, Sociology and Social Phenomena3

Developing Countries International Cooperation Socioeconomic Factors

Information Science4

Prevalence Incidence Molecular Sequence Data Questionnaires

Named Groups4

Infant, Newborn Blood Donors Sexual Partners HIV Long-Term Survivors

Health Care32

HIV Seroprevalence Risk Factors Seroepidemiologic Studies Infectious Disease Transmission, Vertical Post-Exposure Prophylaxis Cohort Studies Medication Adherence Prevalence Treatment Failure Treatment Outcome Prospective Studies Patient Compliance Cross-Sectional Studies Retrospective Studies Incidence Commission on Professional and Hospital Activities Follow-Up Studies Longitudinal Studies Logistic Models Rural Population Case-Control Studies Clinical Trials as Topic Age Factors Multivariate Analysis Odds Ratio Health Services Accessibility Sex Factors World Health Sensitivity and Specificity Socioeconomic Factors Questionnaires Urban Population

Geographicals15

South Africa Uganda Zimbabwe Africa South of the Sahara Malawi Brazil United States Botswana India Zambia Cote d'Ivoire Kenya France Thailand Tanzania

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

HIV Seropositivity HIV Infections HIV Seroprevalence Anti-HIV Agents Antiretroviral Therapy, Highly Active Anti-Retroviral Agents Substance Abuse, Intravenous HIV-1 Risk Factors Sexual Behavior Drug Resistance, Viral CD4 Lymphocyte Count Antibiotic Prophylaxis Viral Load Seroepidemiologic Studies Reverse Transcriptase Inhibitors HIV Protease Inhibitors Zidovudine Benzoxazines Acquired Immunodeficiency Syndrome Nevirapine Drug Resistance, Multiple, Viral Infectious Disease Transmission, Vertical HIV Pregnancy Complications, Infectious Organophosphonates HIV Reverse Transcriptase Indinavir Lopinavir Ritonavir Stavudine Lamivudine Drug Therapy, Combination HIV Protease HIV Fusion Inhibitors RNA, Viral AIDS-Related Opportunistic Infections Nelfinavir Adenine South Africa Pyrimidinones Post-Exposure Prophylaxis Uganda Cohort Studies Medication Adherence Integrase Inhibitors Prevalence HIV Seronegativity Treatment Failure Didanosine HIV-Associated Lipodystrophy Syndrome Treatment Outcome Saquinavir Antibodies, Viral Zimbabwe Pregnancy Viremia Prospective Studies Patient Compliance Africa South of the Sahara Cross-Sectional Studies HIV Integrase Inhibitors Virus Replication Genotype Retrospective Studies Antiviral Agents CD4-Positive T-Lymphocytes Antibodies, Bacterial HIV Wasting Syndrome Dideoxynucleosides pol Gene Products, Human Immunodeficiency Virus Malawi Time Factors Drug Monitoring Immunoglobulin G Chlamydophila pneumoniae Dental Prophylaxis Drug Administration Schedule Infant, Newborn Mutation Chemoprevention Incidence Drug Interactions Serologic Tests Chlamydophila Infections Brazil Developing Countries Oxazines Cyclohexanes Cytomegalovirus Infections Enzyme-Linked Immunosorbent Assay Commission on Professional and Hospital Activities Follow-Up Studies Trimethoprim-Sulfamethoxazole Combination Genes, pol Plasma Drugs, Generic Pyrrolidinones Lipodystrophy Coinfection

No FAQ available that match "prophylaxis antiretroviral drugs hiv seropositivity"